HIT Consultant March 19, 2025
Fred Pennic

What You Should Know:

InformedDNA®, a precision health company focused on revolutionizing the application of genomic insights, has announced its acquisition of Coriell Life Sciences, a provider of pharmacogenomic services and clinical decision support. Financial details of the acquisition were not disclosed.

– The strategic acquisition significantly expands InformedDNA’s capabilities, offering patients, providers, and payers broader access to genetic insights for more personalized and data-driven treatment and medication decisions.

Coriell’s Pharmacogenomics Capabilities

Coriell Life Sciences, based in Philadelphia, specializes in combining pharmacogenomics—the study of how genes affect medication response—with precision medicine to deliver tailored diagnosis and treatment plans. Their services cater to a wide range of clients, including large employers,...

Today's Sponsors

Venturous
Got healthcare questions? Just ask Transcarent

Today's Sponsor

Venturous

 
Topics: Biotechnology, Mergers & Acquisitions / JV, Pharma / Biotech, Trends
Which Biopharma Startups Made the Cut for INVEST Pitch Perfect?
CAR T-Cell Pioneer Plots Technology’s Next Steps
Eli Lilly Adds Alzheimer’s Care to Digital Health Platform Services
GLP-1 drug use for weight loss has soared, costing billions
Fortune: The 61 most innovative companies in healthcare

Share This Article